Podcasts about uterine

First Principles of Abnormal Uterine Bleeding (AUB)Think it's "just PMS"? Think again! In Part I of our AUB series, we dive into what counts as normal menstrual bleeding, when bleeding becomes abnormal, and the common causes behind it. Join us as we unpack the basics of Abnormal Uterine Bleeding and turn a confusing topic into something clear, practical, and surprisingly fascinating.Disclaimer: This episode was recorded on 1 May 2026. At the time of recording, the condition now known as Polycystic Ovarian Morphological Syndrome (PMOS) was referred to as Polycystic Ovary Syndrome (PCOS). Following the official nomenclature change announced on 12 May 2026, the term PMOS is now preferred. References to "PCOS" in this episode reflect the terminology that was in use at the time of recording.

Hey everyone, thanks for tuning in. If you've spent any time in the OR during a cesarean delivery, you know that the choice between uterine exteriorization and in situ repair usually comes down to how you were trained or personal surgeon preference. It's a debate as old as modern obstetrics. But a major piece of clarity is coming down the pipeline. This episode, we are getting a sneak peek at a brand-new systematic review and meta-analysis dropping this July 2026 in the European Journal of OBGYN. We're asking the big question: is this the study that finally settles the debate once and for all? Grab your coffee, stick around, and let's find out.16% OFF TONA ACTIVE WEAR PROMO: https://tonaactive.com/discount/CHAPANOSPINOBG​ Coutinho, I. C., Ramos de Amorim, M. M., Katz, L., & Bandeira de Ferraz, Á. A. (2008). Uterine exteriorization compared with in situ repair at cesarean delivery: A randomized controlled trial. Obstetrics & Gynecology, 111(3), 639–647. https://doi.org/10.1097/aog.0b013e31816521e2 . (One of the most heavily cited clinical trials on the subject. It established that women in the exteriorized group experienced a 41% greater risk of moderate-to-severe pain at 6 hours postoperatively compared to the non-exteriorized cohort).​ Tan, H. S., Taylor, R. C., Sharawi, N., Sultana, R., Barton, K. D., & Habib, A. S. (2021). Uterine exteriorization versus in situ repair in Cesarean delivery: A systematic review and meta-analysis. Canadian Journal of Anaesthesia, 69(2), 216–233. https://doi.org/10.1007/s12630-021-02142-8​ Fonseca Queiroz L, Lemos M, Pereira da Silva D . Uterine exteriorization versus in-situ uterine repair during cesarean delivery: a systematic review and meta-analysis of randomized controlled trial. European Journal of Obstetrics and Gynecology and Reproductive Biology, 2026; 323

It's a QUICKY: IMPROMPTU episode in clinic today..

Is progesterone the same as a progestin? It sounds like it should be. It is absolutely not. And that distinction matters more than most women — and many providers — realize.This is the conversation Dr. Carolyn Moyers has multiple times a day in clinic — especially with women in perimenopause who are trying to understand their options, figure out why a previous hormone regimen made them feel worse, or advocate for a prescription that actually fits their biology. It is also one of the most consequential mix-ups in all of menopause medicine, and it is long overdue for a dedicated episode.Bioidentical progesterone and synthetic progestins are not interchangeable. They have different molecular structures, different receptor profiles, and meaningfully different effects on your breast tissue, your cardiovascular system, your sleep, and your brain. The WHI study — the one that scared a generation of women off hormone therapy — tested a synthetic progestin, not bioidentical progesterone. And the breast cancer finding it reported was not even statistically significant. That context has been almost entirely missing from the public conversation. Until now.In this episode:• What bioidentical progesterone actually is — and how it differs from synthetic progestins at the molecular level• The WHI study: what it actually tested, and why its results have been misapplied for 20+ years• Breast cancer risk: the ESTHER study and what the evidence actually shows• Cardiovascular differences between progesterone and MPA (Provera)• Why progesterone is a neuroactive steroid — and what that means for your sleep, anxiety, and mood• Uterine protection: what it is, why it matters, and whether bioidentical progesterone is sufficient• What to do if you don't have a uterus — and whether you still need progesterone• Perimenopause: why the progestogen conversation is completely different when you still have cycles, variable ovarian function, and potentially need contraception• The levonorgestrel IUD, norethindrone acetate 5mg vs. the minipill, and Slynd (drospirenone 4mg) — what each one does and who it's for• Exactly how to advocate for yourself at your next appointmentResources mentioned:• ESTHER Study (Fournier et al.) — progesterone vs. MPA and breast cancer risk• Women's Health Initiative (2002)• Prometrium prescribing information• Labia Logic (@labialogic) — vulvovaginal specialists | Memorial Day vulvar health post: instagram.com/p/DYqK9uvj2M8• Sky Women's Health Podcast — Episode 158: Progesterone Intolerance | podcasts.apple.com/gb/podcast/episode-158-progesterone-intolerance/id1541657642?i=1000640152675Work with Dr. Moyers: skywomenshealth.com | In-person: Fort Worth, TX | Virtual: Texas & West Virginia

In a special episode from the conference floor at SEUD 2026, Christina Biamis (Senior Editor at eBioMedicine) and Ben Burwood (Senior Editor at The Lancet Obstetrics, Gynaecology, & Women's Health) speak with Prof Charles Chapron, Dr Mathilde Bourdon, Prof Felice Petraglia, Dr Silvia Vannuccini, Dr Lydia Coxon, Dr Ludivine Doridot, Dr Tina Tellum, Dr Devon Evans, and Prof Ludwig Keisel about the latest advances in the treatment of patients with endometriosis, adenomyosis, PCOS, and other uterine disorders. Hear from the experts as they discuss the need for a paradigm shift in the treatment of diseases that affect tens of millions of women worldwide.

Uterine hysterotomy unintended extensions happen. For sure. This has been analyzed over many years, and it is still making news. Look at this mini-timeline: Back in 2018, authors published “Unintended hysterotomy extension during caesarean delivery: risk factors and maternal morbidity”. Moving up the timeline to 2020, others published in J Maternal-Fetal Neonatal Medicine, “Risk factors for uterine incision extension during cesarean delivery”. Then in 2024, in the PINK journal, authors published a related study, “The association between unintended hysterotomy extensions with cesarean delivery and subsequent preterm birth”. In this episode, we will review a new narrative review (in the Green Journal, May 3, 2026) of unintended hysterotomy extension at C-section. We will summarize known risk factors and focus on subsequent uterine rupture risk. Does unintended hysterotomy extension at CS increase TOLAC uterine rupture? It's complicated. Listen in for details.1. Giugale LE, Sakamoto S, Yabes J, Dunn SL, Krans EE. Unintended hysterotomy extension during caesarean delivery: risk factors and maternal morbidity. J Obstet Gynaecol. 2018 Nov;38(8):1048-1053.2. Epub: Unintentional Extensions of the Cesarean Hysterotomy Incision. A Review and Proposed Classification System (May 3, 2026)

Menopause is not just “hot flashes”—it is a systemic hormonal shift that affects almost every organ system. For the emergency clinician, recognizing the symptoms of perimenopause and menopause is crucial for expanding the differential diagnosis once life-threatening conditions are ruled out. Dr. Pam Dyne joins us for a crash course on evaluating menopausal and perimenopausal patients in the ED. The “Why”: Why Menopause Matters in the ED The Mimic: Menopausal symptoms can mimic emergencies, including cardiac events, neurologic issues, and acute musculoskeletal injuries. The “Nothing Bad” Trap: After a negative workup (e.g., for chest pain or abdominal pain), telling a patient “everything is normal” often leaves them without answers. Identifying menopause as a potential etiology provides patient-centered closure and a path to treatment. Empowerment: Many medical providers are insufficiently trained when it come to menopause – ED clinicians can help patients advocate for themselves. Physiology Refresher: When the Ovaries Retire The Signal: Prior to menopause, the brain sends FSH/LH to the ovaries, and the ovaries answer with estrogen. The Shift: In menopause, the ovaries “retire.” The brain keeps shouting (higher FSH levels), but the ovaries don't respond. Perimenopause: Hormones fluctuate wildly, cycles become irregular, and symptoms are often at their peak due to inconsistency. Hormone Therapy (MHT): Debunking the Myths A major barrier to treatment is the “mass hysteria” caused by the 2002 Women's Health Initiative (WHI) study. The Correction: Modern re-analysis shows that for healthy females under 60 and within 10 years of menopause, hormone therapy is extremely safe. (There are some exceptions, including females at high risk for certain cancers) The Benefits: It has been shown to reduce all-cause mortality by 30% and has many potential health benefits, including lower the risk of Alzheimer’s, Parkinson’s, and osteoporotic fractures. The Difficult Pelvic Exam: ED “Hacks” Examining older female patients can be challenging for myriad reasons, including physical limitations and lack of proper ED pelvic exam gurneys. The Upside-Down Speculum: If you can’t use stirrups, keep the patient flat on the bed. Turn the speculum upside down (handle facing up) so it doesn’t hit the gurney. Tip: Push down on the handle; don’t pull up like a laryngoscope. Lateral Decubitus: Perform the exam with the patient on their side (top leg held up) if they cannot flex their hips. Comfort: Use liberal lubrication and consider topical lidocaine gel. The “Hidden” Problem: Always check for old/forgotten pessaries or fecal impaction in cases of pelvic pain or recurrent UTIs. Clinical Pearls: Specific Presentations 1. Post-Menopausal Bleeding Rule: Cancer until proven otherwise. Workup: Speculum exam (confirm source) + Ultrasound (measure endometrial thickness) + Endometrial biopsy (usually outpatient). 2. Genitourinary Syndrome of Menopause (GSM) Symptoms: Vaginal dryness, thinning tissue, pH changes, and recurrent UTIs (≥3 culture-proven UTIs in 12 months or ≥2 in 6 months). ED Treatment: ED docs can and should prescribe vaginal estrogen cream. It is not absorbed systemically and is highly effective at preventing future UTIs. 3. Pelvic Organ Prolapse Types: Cystocele (bladder), Rectocele (rectum), or Uterine prolapse. Exam Tip: Symptoms are often gravity-dependent. If you don’t see the bulge while the patient is supine, ask them to bear down. 4. Musculoskeletal (MSK) Syndrome of Menopause Presentation: atraumatic joint pain, tendinopathies. Cause: Estrogen receptors are located throughout the MSK system; loss of estrogen leads to inflammation and ligamentous changes. Key Takeaways for the ED Clinician Keep menopause on your differential: Don't dismiss vague aches, mood changes, or urinary issues in women aged 45–60 as “just stress.” Look at the Problem: If a patient has pelvic pain or bleeding, do the exam. You might find a simple fix, like a forgotten pessary or local atrophy. Connect to Care: If you suspect menopause is the culprit, point them toward menopause.org to find a certified practitioner. Hosts: Dr. Julia Magaña, Professor of Pediatric Emergency Medicine at UC Davis Dr. Sarah Medeiros, Professor of Emergency Medicine at UC Davis Guest: Dr. Pamela Dyne, Professor of Clinical Emergency Medicine and Chief Physician Wellness Officer at Olive View UCLA Medical Center Resources: North Americal Menopause Society (NAMS) – Menopause.org UTIs and Estrogen: the Overlooked Link, By Ashley Winter, MD; Rachel Rubin, MD; and Howie Mell, MD, MPH. ACEP Now, February 16, 2022 American College of Obstetricians and Gynecologists (ACOG): Menopause *** Thank you to the UC Davis Department of Emergency Medicine for supporting this podcast and to Orlando Magaña at OM Productions for audio production services.

Uterine compression sutures are effective, uterus-sparing techniques for managing severe postpartum hemorrhage (PPH) due to atony, avoiding hysterectomy. Keytypes include the B-Lynch suture (vertical, brace-like), Hayman suture (simplified vertical), and Pereira sutures (multiple, comprehensive sutures), and Cho Compression (quadrant square anterior to posterior closures), are applied when pharmacological methods fail. But these, while helpful with atony, do not address the LUS bleeding from previa which are below these applications. Even the O'Leary lateral sutures are often higher tha the bleeding and thin, anterior LUS affected by previa. Previa is a significant risk factor for PPH. In this episode, we will highlight 3 novel suture techniques which have been in print (TWO as recent as January 2026) which can be effective in stopping the LUS bleeding and avoiding hysterectomy. We will highlight the transverse circumferential purse string, the simple transverse Nausicaa suture, and theLUS WaveForm suture. These are easy to use and may be lifesaving. 1.   Shih J, Li J, Kang J .The Nausicaä suture in the management of the placenta accreta spectrum. AJOG. Jan 2026: 233, S671-S688 S2.   Transverse Purse String Suture for Placenta Previa in the Presence of Previous Cesarean Section, Experience in Northern Borders Saudi Arabia. 20223.    Zhou L et alWave compression suture: A modifieduterus-preserving treatment for placenta previa by reconstruction of the lower uterine segment. Medicine (Baltimore). 2026 Jan 30;105(5):e47468.

Episode 164: Pelvic Organ Prolapse Clean Notes (Review Book) Uterine Prolapse Risk Factors Clinical Presentation Diagnostics Treatment Exam Keys Cystocele Risk Factors Clinical Presentation Diagnostics Treatment Exam Keys Rectocele Risk Factors Clinical Presentation Diagnostics Treatment Exam Keys The post 164 Pelvic Organ Prolapse Made Simple: Uterine Prolapse, Cystocele & Rectocele on Exams appeared first on Physician Assistant Exam Review.

Uterine hemorrhage remains a significant complication following abortion loss and in the postpartum period and contributes to substantial morbidity and mortality among pregnant patients. Although some FDA approved devices are on the market (Bakri balloon and Jada vacuum), they may be cost prohibited in some settings and/or some uterine cavities may be very small for either option, like after a mid-second trimester or early third trimester PPH. But every delivery unit has some form of suction tool and wall suction ability. This is where FOCUS*, STUT, and/or U-CaVIT come into play. And now there is new data on this from the AJOG (epub, April 2026). Listen in for details. (*Shout Out to Dr. Frank Jackson for his work on this as well).1. Singata-Madliki et al. Suction Tube Uterine Tamponade Versus Uterine Balloon Tamponade for Treatment of Refractory Postpartum Hemorrhage: A Randomized Clinical Feasibility Trial. International Journal of Gynaecology and Obstetrics: The Official Organ of FIGO. July 2025. (South Africa)2. Hofmeyr GJ, Singata-Madliki M. Novel Suction Tube Uterine Tamponade for Treating Intractable Postpartum Haemorrhage: Description of Technique and Report of Three Cases. BJOG : An International Journal of Obstetrics and Gynaecology. 20203. Jackson FI, Dilena NJ, Abelman SH, Blitz MJ, Gerber S. Hemorrhage management using a Foley catheter for uterine suction. Am J Obstet Gynecol. 2025 Nov;233(5):503-504. 4. ACOG Practice Bulletin No. 183: Postpartum Hemorrhage. Obstetrics and Gynecology. 2017. 5. Ranieri E, Kalimeris S, Ochsenbein N, Haslinger C, Vacuum-Induced Tamponade Using Urological Catheters for Postpartum Hemorrhage, American Journal of Obstetrics and Gynecology (2026), doi: https://doi.org/10.1016/j.ajog.2026.04.026

Send us Fan MailWhat if your timing was perfect every month — great cervical mucus, a clear LH surge, a healthy luteal phase — and still no positive test? For some women, the missing piece is not ovulation at all. It is the uterine lining that receives the embryo, and whether that environment is truly ready to support implantation.In this episode of Cycle Wisdom, Dr. Monica Minjeur unpacks endometrial receptivity — what a thin uterine lining actually means, how estrogen and progesterone work together to prepare it, and the stepwise, cycle-timed plan to improve thickness, blood flow, and function without jumping straight to procedures. Through the story of Aubrey, a 33-year-old who had been told she might need IVF after a thin lining was found on ultrasound, you will see how targeted evaluation and a few key changes transformed her results within three cycles.You will learn:What endometrial thickness numbers actually mean and what to look for on ultrasoundWhich underlying causes — insulin resistance, low iron, poor estradiol response — quietly thin the liningHow to improve uterine lining through cycle-timed lifestyle, nutrient, and hormone supportIf implantation has felt like the missing piece in your fertility journey, there may be more answers available than you have been given. Learn more or schedule a free discovery call at radiantclinic.com.

If your IVF transfer failed despite a good embryo, normal lining, and a smooth protocol, you may have been told it was "just bad luck." But failed implantation with a euploid or high-quality embryo is not random. It often means key biological factors were never fully evaluated before the transfer. You followed the plan. The embryo looked good. The lining was "fine." And it still didn't work. This is where many people get stuck. Not because there are no answers, but because no one stepped back to assess the full picture before repeating another transfer. In this episode, we break down why embryo quality alone does not determine implantation and what is often missed when a transfer fails. In this episode, you'll learn: Why a good embryo does not guarantee implantation The three biological layers that influence whether implantation happens How uterine environment, hormone timing, and systemic health interact What subtle inflammation and thyroid patterns can do to implantation What to review before transferring another embryo I'm Sarah Clark, founder of Fab Fertile and host of Get Pregnant Naturally. For over a decade, my team and I have reviewed hundreds of low AMH and failed IVF cases using functional testing alongside conventional fertility care. We specialize in helping couples identify the physiological patterns driving poor outcomes so decisions are grounded in interpretation, not guesswork. If you've been moving from cycle to cycle without a clear way to evaluate what's actually been addressed, I created a free resource called the Embryo Audit Checklist. It helps you organize past cycles and labs so you can see what's been looked at and what may not have been considered yet. Access it here.

In today's episode, we have the pleasure of chatting with Dr. Kosta Simintiras, Assistant Professor of Reproductive and Developmental Biology at Lousiana State University. Dr. Simintiras studies mechanisms of communication between maternal and embryonic tissues that are essential for establishing early pregnancy in mammals. His lab uses a combination of model systems including cattle, transgenic rodents, and organoids grown from human cells, with the ultimate goal of understanding of how pregnancy works both when it goes well, and when it doesn't. Learn more about SSR here: https://ssr.org/Learn more about the LSU Simintiras Lab here: https://faculty.lsu.edu/csimintiras/index.phpLink to some of Dr. Simintiras' relevant work in SSR's flagship journal The Biology of Reproduction: https://academic.oup.com/biolreprod/article/114/1/134/8239143?guestAccessKey=

In this episode of To The Root, Robyn Spangler shares her journey through recurrent pregnancy loss after five pregnancies, including chemical pregnancies, a miscarriage, and an ectopic pregnancy.She breaks down her medical timeline, the limitations of conventional fertility care, and the deeper testing she pursued to uncover root causes. Robyn highlights key findings that shaped her treatment plan and emphasizes the importance of self-advocacy and personalized care.This episode offers insight and guidance for anyone seeking a deeper understanding of fertility challenges and potential underlying factors.Tune in now!If you haven't yet listened to Part 1 of this series, we encourage you to go back and tune in to hear the beginning of Robyn's journey—including the story behind Scottie and the song written for her: https://www.theclearskinlab.com/opt-in/to-the-root-podcast Highlights:A detailed timeline of Robyn's recurrent pregnancy loss journeyClinical distinctions between chemical pregnancies, miscarriage, and ectopic pregnancyOverview of standard fertility workups and their limitationsThe role of advanced and self-directed testing in identifying potential root causesInsights into uterine health, microbiome imbalances, and chronic endometritisFindings from surgical evaluation, including uterine septum identification and repairConsiderations around sperm quality and DNA fragmentationThe importance of patient advocacy within the fertility care systemEmotional considerations when navigating repeated loss and uncertaintyKey interventions that contributed to a successful pregnancy outcomeConnect with Robyn:Instagram: @nutritionbyrobyn Website: https://www.theclearskinlab.comTesting & Resources Mentioned:Tests/procedures with did with the fertility doc:-Full recurrent loss panel-Progesterone-All the hormone tests-immune & inflammation labs-АМН-Full thyroid health-Blood clotting factors-Genetics (including mthfr & karyotype)-Laparoscopy procedure to screen for endometriosis-Hysteroscopy + checking for open tubes-Uterine lining checks-Uterine biopsy (with plasma cell testing) during hysteroscopy procedure -Sperm testing with DNA fragmentation (multiple- via fertility clinic & on our own via  Legacy   Use code Robyn for a discount.Testing we did on our own:-Sperm Analysis with DNA fragmentation - via Legacy  Use code Robyn for a discount.-Mold/mycotoxins - Vibrant Wellness* -Minerals - HTMA via Trace Elements*-Heavy metals- via HTMA Trace Elements*-Stool tests- Via GI MAP*-Fertilysis- Female microbiome Test (tests vagina and uterus microbiome)-Fertilysis - Reproductive Immunology Test-Evvy vaginal microbiome testing-plasmalogen testing via Prodrome Science*Any tests with a * are only available via licensed practitioners which I was able to order given my profession.

Could a single overlooked supplement be the missing piece to improving implantation and getting pregnant faster? Most women focus on ovulation and hormones—but your uterine lining is just as critical for pregnancy success. If your lining isn't thick, nourished, and receptive, implantation can't happen—no matter how “perfect” everything else looks. And this is where many fertility journeys quietly stall.In this episode you'll learn...-Learn why uterine lining thickness and quality are essential for implantation-Understand how vitamin E improves blood flow, reduces inflammation, and supports progesterone-Discover how to properly use vitamin E for maximum fertility benefitsHit play now to learn how to optimize your uterine lining and give implantation the best possible chance.

Fitness Week 17.2 (multiple topics, see notes below). Topics: (none of these topics are professional or medical advice, I'm speaking to my own experiences for entertainment purposes only, consult doctors for any of your own situations).​Uterine health/ menstrual cycles: Advil, tranexamic acid, fibroids, ginger root and dandelion root tea​Iron 15mg daily w/o caffeine within 2 he before or afterwards​Mediterrenean meal plans ​Protein shake​Gut health: hydration, constipation, sedentary lifestyle and gut motility​Back pain (possibly sciatica): foam rolling, stretches​Interviewing​Momomuscle.com: scroll to the bottom for freebies

Uterine fibroids may affect up to 80 percent of women in their lifetime, but they remain under-researched, underfunded, and routinely dismissed. Lupita Nyong'o is working to change that. "I could not believe that women were partially or wholly losing their reproductive organs because of this noncancerous tumor situation." On this episode, Dr. Joel Bervell talks with Academy Award–winning actor and activist Lupita Nyong'o about her own diagnosis, and her decision to share an MRI of her body while launching the Make Fibroids Count campaign with the Foundation for Women's Health. "I realized without research we can't get any further," Nyong'o says. "We need to understand more in order to be able to equip the doctors who can then equip the patients." Show Notes: Lupita Nyong'o Make Fibroids Count (through the Foundation for Women's Health) The White Dress Project The Fibroid Foundation

Fertility specialist Oluyemisi Famuyiwa discusses her article "Uterine aging in IVF: Why the 'soil' matters as much as the seed." Oluyemisi explains that while clinicians often focus on egg quality, the aging of the uterus itself is a frequently overlooked factor in implantation failure. She explores clinical data showing that even with chromosomally perfect embryos, success rates decline as the endometrium loses its resilience due to cellular senescence and weakened progesterone signaling. The conversation challenges the standard "seed and soil" analogy by revealing that normal ultrasound thickness does not guarantee a receptive environment for pregnancy. Oluyemisi advocates for a precision medicine approach that scrutinizes the uterine environment as rigorously as the embryo to refine hope for patients. Discover how acknowledging the biological history of the uterus can transform unexplained failure into actionable data. Partner with me on the KevinMD platform. With over three million monthly readers and half a million social media followers, I give you direct access to the doctors and patients who matter most. Whether you need a sponsored article, email campaign, video interview, or a spot right here on the podcast, I offer the trusted space your brand deserves to be heard. Let's work together to tell your story. PARTNER WITH KEVINMD → https://kevinmd.com/influencer SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

Bongani Bingwa speaks to Sindiswa Mzamo, Director and Global President of the Circle of Business Women about women’s health with a focus on uterine health, from menstrual wellbeing to overall reproductive function and the ability to carry a pregnancy, an issue affecting millions of women across the continent, yet still too often spoken about in whispers. On the sidelines of the African Union Summit in Addis Ababa, South African health leader Dr Vivian Mokome, alongside Fatima Moyane, led a high-level discussion calling for women’s health to be recognised as a core part of primary healthcare rather than an afterthought, underscoring the importance of dignity, early detection and improved access to quality care, and reinforcing the need to place women’s health at the centre of Africa’s development agenda in line with Agenda 2063, arguing that economic growth and sustainable progress are impossible without prioritising the health and wellbeing of women. 702 Breakfast with Bongani Bingwa is broadcast on 702, a Johannesburg based talk radio station. Bongani makes sense of the news, interviews the key newsmakers of the day, and holds those in power to account on your behalf. The team bring you all you need to know to start your day Thank you for listening to a podcast from 702 Breakfast with Bongani Bingwa Listen live on Primedia+ weekdays from 06:00 and 09:00 (SA Time) to Breakfast with Bongani Bingwa broadcast on 702: https://buff.ly/gk3y0Kj For more from the show go to https://buff.ly/36edSLV or find all the catch-up podcasts here https://buff.ly/zEcM35T Subscribe to the 702 Daily and Weekly Newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook: https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio7See omnystudio.com/listener for privacy information.

Bongani Bingwa speaks to Sindiswa Mzamo, Director and Global President of the Circle of Business Women about women’s health with a focus on uterine health, from menstrual wellbeing to overall reproductive function and the ability to carry a pregnancy, an issue affecting millions of women across the continent, yet still too often spoken about in whispers. On the sidelines of the African Union Summit in Addis Ababa, South African health leader Dr Vivian Mokome, alongside Fatima Moyane, led a high-level discussion calling for women’s health to be recognised as a core part of primary healthcare rather than an afterthought, underscoring the importance of dignity, early detection and improved access to quality care, and reinforcing the need to place women’s health at the centre of Africa’s development agenda in line with Agenda 2063, arguing that economic growth and sustainable progress are impossible without prioritising the health and wellbeing of women. 702 Breakfast with Bongani Bingwa is broadcast on 702, a Johannesburg based talk radio station. Bongani makes sense of the news, interviews the key newsmakers of the day, and holds those in power to account on your behalf. The team bring you all you need to know to start your day Thank you for listening to a podcast from 702 Breakfast with Bongani Bingwa Listen live on Primedia+ weekdays from 06:00 and 09:00 (SA Time) to Breakfast with Bongani Bingwa broadcast on 702: https://buff.ly/gk3y0Kj For more from the show go to https://buff.ly/36edSLV or find all the catch-up podcasts here https://buff.ly/zEcM35T Subscribe to the 702 Daily and Weekly Newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook: https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio7See omnystudio.com/listener for privacy information.

What if the symptoms you have been told are “just part of hormonal changes and perimenopause” are actually a misdiagnosed medical condition that's progressively getting worse without being properly addressed?In this episode of Maximizing Hormones, Physique, and Running Through Perimenopause, Louise Valentine, one of the world's leading integrative health practitioners and exercise physiologists, sits down with Dr. Ryan Armstrong to break down fibroids, chronic pain, and vascular issues in a way that finally makes sense. Together, they explore why heavy bleeding, chronic fatigue, knee pain, plantar fasciitis, and leg cramping are so common in active women and why they should never be ignored or normalized.Dr. Ryan explains minimally invasive treatments like uterine fibroid embolization that preserve the uterus while dramatically improving quality of life, often with faster recovery and fewer long-term risks than traditional surgery. Louise adds critical context around hormone balance, nutrition, and strength training, showing how medical care, targeted fitness and lifestyle strategies work best together.Listeners will walk away with clarity around symptoms to watch for, questions to ask their doctors, and reassurance that there are modern, effective options that do not require extreme or life-altering procedures. This episode is empowering, practical, and especially valuable for women who want to stay active, strong, and pain-free through perimenopause and beyond.Learn more about Dr. Armstrong's practice Texas Endovascular at https://texaseva.com/ Learn & level up with my free nutrition guide and award-winning Badass Breakthrough Academy to thrive through perimenopause with less stress: https://www.breakingthroughwellness.com/Link to our FullScript where you can see curated best supplement picks & save 20%: https://us.fullscript.com/welcome/breakingthroughwellness/store-start Take advantage of our podcast listener discount and save 20% off all of Kion's science-backed clean products. Code "LOUISE" saves on all future orders: https://www.getkion.com/pages/maximizing Episode Highlights:(0:00) Intro and natural hormone balance for long-term relief(3:00) Fibroids explained in simple terms(6:10) Hormones, inflammation, and injury risk(12:50) Uterine fibroid embolization explained(18:11) Risks of hysterectomy and why alternatives matter(20:38) Innovative treatments for knee pain and plantar fasciitis(23:29) Venous insufficiency, cramping, and varicose veins(30:20) Heavy bleeding, anemia, and athletic performance(32:29) Ablation vs embolization for fibroid care(36:06) OutroTune in weekly to "Maximizing Hormones, Physique, and Running Through Perimenopause" for our simple female-specific science-based revolution. Let's unlock our best with less stress!I'd love to connect! Email

It's a controversial topic: the impact of uterine incision (hysterectomy) on the neonate delivery interval (also called the U-D interval). Does it matter? Just to be clear, we're talking about time from uterine entry to fetal extraction, not skin incision to fetal extraction. Past publications have produced conflicting results, often limited by small sample sizes, heterogeneous indications for delivery, and reliance on surrogate markers (like apgar scores) rather than clinical morbidity. But a new study published in the Gray journal at the end of 2025 (December 30, 2025) gives some new insights. In this episode, we will review this retrospective study and play the “Devil's advocate” as we summarize the rebuttal data. As the reports are conflicting, we will end the podcast with a real-world interpretation and application of this data. Listen in for details. 1. Bart, Yossi et al. Uterine Incision-to-Delivery Interval and Neonatal Outcomes among Non-urgent, Term, Cesarean Deliveries. American Journal of Obstetrics & Gynecology, Volume 0, Issue 0. https://www.ajog.org/article/S0002-9378(25)00980-9/fulltext?rss=yes2. Maayan-Metzger A, Schushan-Eisen I, Todris L, Etchin A, Kuint J. The effect of time intervals on neonatal outcome in elective cesarean delivery at term under regional anesthesia. Int J Gynaecol Obstet. 2010 Dec;111(3):224-8. doi: 10.1016/j.ijgo.2010.07.022. Epub 2010 Sep 19. PMID: 20855070. https://pubmed.ncbi.nlm.nih.gov/20855070/3. Spain JE, Tuuli M, Stout MJ, Roehl KA, Odibo AO, Macones GA, Cahill AG. Time from uterine incision to delivery and hypoxic neonatal outcomes. Am J Perinatol. 2015 Apr;32(5):497-502. doi: 10.1055/s-0034-1396696. Epub 2014 Dec 24. PMID: 25539409.4. Bader AM, Datta S, Arthur GR, Benvenuti E, Courtney M, Hauch M. Maternal and fetal catecholamines and uterine incision-to-delivery interval during elective cesarean. Obstet Gynecol. 1990 Apr;75(4):600-3. PMID: 2107478.5. Tekin, E., Inal, H.A. & Isenlik, B.S. A Comparison of the Effect of Time from Uterine Incision to Delivery on Neonatal Outcomes in Women with One Previous and Repeat (Two or More) Cesarean Sections. SN Compr. Clin. Med. 5, 80 (2023). https://doi.org/10.1007/s42399-023-01427-x

Uterine rupture or dehiscence associated with TOLAC results in the most significant increase in the likelihood of additional maternal and neonatal morbidity. It should be noted that the terms “uterine rupture” and “uterine dehiscence” are not consistently distinguished from each other in the literature and often are used interchangeably. Furthermore, the reported incidence of uterine rupture varies in part because some studies have grouped true, catastrophic uterine rupture together with asymptomatic scar dehiscence. In January 2026, a new meta-analysis examines the relationship between oxytocin use with TOLAC and uterine rupture. In this episode, we will summarize the key findings in that study and review the data on the use of internal monitors during TOLAC. Do internal monitors (FSE, IUPC) offer a safer TOLAC compared with external monitors? Listen in for details.1. Nicolì, Pierpaolo et al.Oxytocin dosing during trial of labor after cesarean to minimize the risk of uterine rupture: a systematic review and meta-analysisAmerican Journal of Obstetrics & Gynecology MFM, Volume 8, Issue 1, 1018462. Practice Bulletin No. 184: Vaginal Birth After Cesarean Delivery. Obstetrics & Gynecology 130(5):p e217-e233, November 2017. | DOI: 10.1097/AOG.00000000000023983. ACOG Clinical Practice Guideline No. 10:Intrapartum Fetal Heart Rate Monitoring: Interpretation and Management. Obstetrics & Gynecology 146(4):p 583-599, October 2025. | DOI: 10.1097/AOG.00000000000060494. Bruno AM, Allshouse AA, Metz TD. Maximum Oxytocin Dose and Uterine Rupture During Trial of Labor After Cesarean. Obstet Gynecol. 2025 Dec 1;146(6):843-850. doi: 10.1097/AOG.0000000000006106. Epub 2025 Oct 30. PMID: 41325062.

Abnormal Uterine Bleeding is a term that is used to describe abnormal variations in menstruation, and include menorrhagia and heavy menstrual bleeding. In this video we cover what are the causes for abnormal uterine bleeding using the mnemonic PALM COEIN. Also included is the treatment for abnormal uterine bleeding. PDFs available here: https://rhesusmedicine.com/pages/gynecologyConsider subscribing (if you found any of the info useful!): https://www.youtube.com/channel/UCRks8wB6vgz0E7buP0L_5RQ?sub_confirmation=1Buy Us A Coffee!: https://www.buymeacoffee.com/rhesusmedicineTimestamps:0:00 What is Abnormal Uterine Bleeding (Definition)0:53 Causes of Abnormal Uterine Bleeding (PALM COEIN Mnemonic)3:26 Diagnosis of Abnormal Uterine Bleeding5:34 Abnormal Uterine Bleeding TreatmentLINK TO SOCIAL MEDIA: https://www.instagram.com/rhesusmedicine/ReferencesBMJ Best Practice (2025) Abnormal uterine bleeding: symptoms, diagnosis and treatment. Last reviewed: 29 Nov 2025; Last updated: 14 Nov 2025. Available at: https://bestpractice.bmj.com/topics/en-gb/658. BMJ Best PracticeMSD Manuals Professional Edition (2024) Abnormal uterine bleeding. Reviewed/Revised Jan 2023; Modified Mar 2024. Available at: https://www.msdmanuals.com/en-gb/professional/gynecology-and-obstetrics/menstrual-abnormalities/abnormal-uterine-bleeding. MSD ManualsWouk, N. and Helton, M. (2019) Abnormal uterine bleeding in premenopausal women, American Family Physician, 99(7). AAFPFIGO Menstrual Disorders Committee (2018) PALM-COEIN classification for AUB causes, Int J Gynaecol Obstet, 143(3), pp. 393–408. MSD ManualsAbnormal uterine bleeding (2024) Wikipedia. Available at: https://en.wikipedia.org/wiki/Abnormal_uterine_bleeding. en.wikipedia.orgDisclaimer: Please remember this podcast and all content from Rhesus Medicine is for educational and entertainment purposes only and is not a guide to diagnose or to treat any form of condition. The content is not to be used to guide clinical practice and is not medical advice. Please consult a healthcare professional for medical advice.

In this episode of the Jack Westin MCAT Podcast, Mike and Molly break down one of the most confusing and heavily tested topics in MCAT Biology: the menstrual cycle.Instead of memorizing hormone charts and phase names, we focus on understanding the story behind the cycle so you can answer any MCAT question, even when it's asked in an unfamiliar way.We cover:

In this episode, we review the high-yield topic of ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Uterine Rupture⁠⁠⁠⁠⁠ from the Obstetrics section at ⁠⁠⁠⁠Medbullets.com⁠⁠⁠⁠⁠⁠Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets

Click here to send me a quick message :) Holy mama! This week is monumental and I want to honor it with you because this podcast would be nothing without the community of thousands of listeners who have tuned in over time. THANK YOU.Today marks episode 200!! So I decided to craft a simple episode highlighting the power of celebration -- to embody the practice of celebrating (including 2 of my biggest celebrations from this podcast journey) and invite you to join me in this podcast party too.A lot of times we associate the buoyancy of summer with joy and celebration. But ancestral traditions across cultures also come together in the darkest nights of the year to find and bring the light into the darkness, often together, often in celebration. So, while this time of the year has a very different quality than bright summer days, it is an entirely appropriate time to tune into quiet reflection and receptivity AS you are also finding the guiding light and celebration.So please join me in celebrating Herbal Womb Wisdom's 200th episode!! In whatever ways feel great for you.Resources:Today's shownotes: The medicine of celebrationJoin the waitlist: Natural Contraception, The Herbal WayEpisode 19: Pelvic liberation and softening w Chaya Leia AronsonEpisode 61: Pelvic wisdom - healing trauma w Dr Emily WilsonEpisode 77: Myofascial release for pelvis + chest w Lindsay CourcelleEpisode 119: Clearing womb trauma w Dr Sarah WylieEpisode 141: Uterine unwinding w Dr Kathryn KloosEpisode 192: Pleasure as medicine w Dr Emily WilsonIf you loved this episode, share it with a friend, or take a screenshot and share on social media and tag me @herbalwombwisdom.  And if you love this podcast, leave a rating & write a review! It's really helpful to get the show to more amazing humans like you.  ❤️DISCLAIMER: This podcast is for educational purposes only, I am not providing any medical advice, I am not a medical practitioner, I'm an herbalist and in the US, there is no path to licensure for herbalists, so my role is as an herbal educator. Please do your own research and consult your healthcare provider for any personal health concerns.Support the show

Uterine fibroids explained Guest Bio Dr. John Lipman, MD, is the Founder and Medical Director of the Atlanta Fibroid Center, a state-of-the-art medical facility that specializes in the nonsurgical treatment of uterine fibroids and has cared for women from throughout the world.

On today's episode of The Wholesome Fertility Podcast, Michelle dives into one of the most emotionally challenging topics on the fertility journey,  repeated miscarriages and failed embryo transfers. While these experiences can feel devastating, Michelle explains that they're not always inevitable. With the right testing and deeper understanding of hidden factors like thyroid health, uterine microbiome, immune responses, and even sperm compatibility, many pregnancy losses and failed transfers can actually be prevented. This episode sheds light on overlooked tests, lifestyle changes, and integrative approaches that can make all the difference in achieving a healthy pregnancy. If you've been through multiple losses or are preparing for a transfer, this conversation is filled with empowering insights and practical next steps that could change your path forward. Key Takeaways: Discover why thyroid imbalances and undiagnosed autoimmune issues can silently sabotage implantation. Learn how the uterine microbiome and inflammation might be the missing piece in your fertility journey. Find out which antioxidant-rich supplements and lifestyle shifts can boost egg and sperm quality. Understand how immune or clotting factors can interfere with pregnancy — and what tests can uncover them. Explore how emotional healing and nervous system regulation can prepare your body to receive new life. Disclaimer: The information shared on this podcast is for educational and informational purposes only and is not intended as medical advice. Please consult with your healthcare provider before making any changes to your health or fertility care. Join me inside The Wholesome Fertility Collective. https://www.michelleoravitz.com/thewholesomefertilitycollective  Vaginal Microbiome test: https://www.fertilysis.com Use coupon code WHOLESOMEFERTILITY Ready to discover what your body needs most on your fertility journey? Take the personalized quiz inside The Wholesome Fertility Journey and get tailored resources to meet you exactly where you are:  https://www.michelleoravitz.com/the-wholesome-fertility-journey For more about my work and offerings, visit: www.michelleoravitz.com Curious about ancient wisdom for fertility? Grab my book The Way of Fertility: https://www.michelleoravitz.com/thewayoffertility Join the Wholesome Fertility Facebook Group for free resources & community support: https://www.facebook.com/groups/2149554308396504/ Connect with me on social: Instagram: @thewholesomelotusfertilityFacebook: The Wholesome Lotus

Uterine fibroids explained Myomectomy and hysterectomy are two common surgical options presented to women with uterine fibroids, but a less invasive alternative is often overlooked. In this Live Foreverish episode, Dr. Mike and Dr. Crystal sit down with Dr. John Lipman to discuss the uterine fibroid embolism procedure and how it is transforming women's lives. #LELEARN #EDULFsocial Guest Bio Dr. John Lipman, MD, is the Founder and Medical Director of the Atlanta Fibroid Center, a state-of-the-art medical facility that specializes in the nonsurgical treatment of uterine fibroids and has cared for women from throughout the world.

Infertility isn't always about age or hormones—sometimes the real culprits are hidden, silent root causes that standard medicine rarely investigates. In this powerful conversation, we explore the cutting-edge research and clinical insights that are changing the way we understand fertility struggles and recurrent pregnancy loss.Joining me on this episode is Dr. Natalie Underberg, a leading voice in functional medicine, women's health, and fertility. She runs her own private practice, and she is also the founder of FIG Wellness, a faith-based supplement company known for its science-backed formulations and their leading HIS&HERS prenatal vitamins — world-class products that feature industry-leading doses of crucial nutrients like 900 mg of choline, setting a new standard in perinatal nutrition and were formulated specifically by Dr. Natalie and her husban,d Dr. Jake.Dr. Natalie has helped hundreds of couples achieve natural pregnancies by uncovering and addressing the root causes of hormonal imbalances, PCOS, gut dysfunction, and recurrent pregnancy loss. She is also the creator of The PCOS Collective and The Pregnancy Prep Academy — educational programs designed to empower women to take control of their health and fertility with personalized, root-cause care.Her work blends clinical expertise, real-life experience, and faith-centered guidance to support couples in stewarding their health and fertility naturally, without unnecessary medications or fertility procedures.

This episode discusses the varied etiologies and a basic workup for a common gynecologic complaint: abnormal uterine bleeding. (Originally released July 2019)  Twitter: @creogsovercoff1 Instagram: @creogsovercoffee Facebook: www.facebook.com/creogsovercoffee Website: www.creogsovercoffee.com Patreon: www.patreon.com/creogsovercoffee Visit www.acog.org to learn more about the CREOG National Residency Curriculum coming Fall 2025.

In this episode of The Birth Trauma Mama Podcast, Kayleigh sits down with Christine, a mom of four, to share her harrowing and powerful story of surviving a rare and life-threatening birth and postpartum experience.After being induced at 37 weeks for hypertension, Christine's delivery with her fourth son, Caden, started calmly, until everything changed. What followed was a series of medical emergencies including a cervical tear, uterine rupture, hemorrhage, and emergency exploratory surgery, followed by multiple re-hospitalizations and near-death experiences in the weeks after giving birth.Christine opens up about the long physical and emotional recovery that followed, from memory loss and PTSD to regaining her strength through pelvic floor physical therapy, and how her desire to understand what happened to her body led to deep reflection on communication gaps in healthcare.Together, Kayleigh and Christine explore:

Uterine fibroids (1:30), community-based residency training (6:40), glucagon-like peptide-1 medications (9:00), heart failure with preserved ejection fraction (12:30), intravenous vs oral iron (15:40), nicotine e-cigarettes for smoking cessation (18:10), and spooky health trends—are they real or fake? (20:10; music: Tocatta and Fugue in D Minor, Kevin MacLeod, CC-BY-3.0).

Got a question?

Things get even darker, wetter, and more horrifying as our intrepid crew delve deeper into Qliphoth. Farnesse and Isidro gain some much needed confidence thanks to our old pal McGuts the Crime Struggler (80s kids will understand that obscure reference…maybe), and some very powerful beings emerge to both help and hinder our heroes: Slan, Skull Knight, and the essence of Darkness itself!

In this episode of The Birth Trauma Mama Podcast, we are joined by Angel, who shares her powerful story of birth, near-death, and healing after a rare and life-threatening complication: uterine inversion.Angel describes how her labor started smoothly and seemed “perfect" until the unexpected happened. What followed was a cascade of emergencies, including massive blood loss, emergency surgery, a hysterectomy, and days in critical care. Angel walks us through the terrifying moments of saying goodbye to her husband, the prayers she whispered before surgery, and the relief of waking up alive.But her story doesn't end at survival. Angel opens up about the aftermath, the postpartum depression she never expected, the shame of feeling broken despite being grateful, and the ongoing work of therapy, community, and healing.In this episode, Angel shares:

Kimberly Peters, a stage four uterine cancer patient at UC San Diego Health, urges government leaders not to cut science funding. She warns that reduced federal support risks delaying vital research and life-saving cures. [Health and Medicine] [Show ID: 41071]

Study Discovers Increased Cancers After MRNA Vaccines, Bret Weinstein- Covid & mRNA: Harms and Damages Exposed Bret Weinstein- Covid & mRNA: Harms and Damages Exposed (NEW!) REMINDER: CDC Didn't Track VAERS Safety Signals John Campbell- Increased cancers after mRNA vaccines   Study- Covid & mRNA: Harms and Damages Exposed (NEW!) | DarkHorse https://youtu.be/zkrbZmYuRoY?si=_0yO0y5ftLacoVJ1 Bret Weinstein 512K subscribers 25,699 views Sep 5, 2025 A new article on the harms and hazards of both SARS-CoV2 and the mRNA biologics said to counter the virus. Full Episode: https://youtube.com/live/wQWkKrM3Dt8 Mentioned in this segment: Zywiec et al 2025. COVID-19 Injections: Harms and Damages, a Non-Exhaustive Conclusion. Journal of American Physicians and Surgeons, 30(3): https://jpands.org/vol30no3/zywiec.pdf ***** Join us on Locals! Get access to our Discord server, exclusive live streams, live chats for all streams, and early access to many podcasts: https://darkhorse.locals.com Heather's newsletter, Natural Selections (subscribe to get free weekly essays in your inbox): https://naturalselections.substack.com Our book, A Hunter-Gatherer's Guide to the 21st Century, is available everywhere books are sold, including from Amazon: https://amzn.to/3AGANGg (commission earned) Check out our store! Epic tabby, digital book burning, saddle up the dire wolves, and more: https://darkhorsestore.org   REMINDER: CDC Didn't Track VAERS Safety Signals | DarkHorse https://youtu.be/u3UAyr6s7xc?si=VUoenskCyMdViArS Bret Weinstein 512K subscribers 16,906 views Sep 5, 2025 RFK Jr. fires the new director, after which other CDC officials resign, and eight former directors of the CDC pen a letter to the New York Times arguing that Kennedy is a hazard to our health. Bret Weinstein and Heather Heying discuss "The Plot Against Kennedy" in Episode 292 of The Evolutionary Lens. Full Episode: https://youtube.com/live/wQWkKrM3Dt8 Mentioned in this segment: NYT op-ed #2 from former CDC directors: We Ran the C.D.C.: Kennedy Is Endangering Every American's Health: https://www.nytimes.com/2025/09/01/op... Bret and Heather 132nd DarkHorse Podcast Livestream: 50 States not in a Roe https://youtube.com/live/usP2D_qGUZs CDC didn't monitor VAERS for COVID safety signals (June 2022): https://childrenshealthdefense.org/de...   Increased cancers after mRNA vaccines Watch this video at- https://youtu.be/3dnIGqUlluc?si=sDbAdXTgOsCiCLev Dr. John Campbell 3.25M subscribers 143,152 views Sep 5, 2025 COVID-19 vaccination, all-cause mortality, and hospitalization for cancer: 30-month cohort study in an Italian province https://pubmed.ncbi.nlm.nih.gov/40881... https://pmc.ncbi.nlm.nih.gov/articles... https://www.thefocalpoints.com/p/brea... The rate of first hospitalization for cancer of any site Unvaccinated group: 0.85% Vaccinated group (one or more doses): 1.15% N = 296,015 population Hospital admission with a cancer diagnosis, 3,124 (p less than 0.001). Vaccination with at least one dose Colon-rectal cancer HR: 1.34 Breast cancer HR: 1.54 Bladder cancer HR: 1.62 After three or more vaccine doses Breast cancer HR: 1.36 Bladder cancer HR: 1.43 All significant After one dose (180 days after) Rate of first hospital admissions for cancers All cancers: up 23% significant Colorectal: up 34% significant Lung: down = 10% Breast: up 54% significant Uterine: up = 75% Ovarian: up = 65% Prostate: up = 1% Bladder: up 62% significant Thyroid: up =58% Haematological: up = 33% After three dose (180 days after administration of third dose) All cancers: up = 9% Colorectal: up = 14% Lung: down = 5% Breast: up=36% significant Uterine: up = 20% Ovarian: up = 86% Prostate: down = 3% Bladder: up=43% significant Thyroid: down = 3% Haematological: up = 5% More about the study Population-wide cohort analysis Evaluating the risk of all-cause death and cancer hospitalization by SARS-CoV-2 immunization status. National Health System official data, entire population, Pescara province, Italy Followed from June 2021 (six months after the first vaccination) to December 2023. 296,015 residents aged ≥11 years Hospital admission with a cancer diagnosis, 3,124 16.6% were unvaccinated 83.3% received ≥1 dose 62.2% ≥3 doses. Compared with the unvaccinated, those receiving ≥1 dose showed a significantly lower likelihood of all-cause death Cancer hospitalization was significant only among the subjects with no previous SARS-CoV-2 infection Some cancer risks went down after 1 year (relative to 180 days) (But breast, ovarian and bladder went up at one year relative to 180 days after 1 vaccine dose) Given that it was not possible to quantify the potential impact of the healthy vaccinee bias and unmeasured confounders, these findings are inevitably preliminary.  

Did you know that you have bacteria in your uterus? And that the types of bacteria there may impact whether you get pregnant or not. We talk all about this and many other things we are discovering are impacting fertility with our guest, Dr. Jaclyn Smeaton. She is a fellow naturopathic doctor who has focused much of her career on fertility, and we can't wait to share this informative episode with you.This episode is sponsored by:Redmond Salt >> Click here and use code HEALTHYMOTHER to save 15% on your order.Needed >> Click here and use code HEALTHYMOTHER to save 20% off your first order.Lumebox >> Click here and use code HEALTHYASAMOTHER for $260 off.Resources From This Episode:DUTCH testWatch the video episode on YouTube HERE!Stay Connected With Us:Healthy As A Mother: www.healthyasamother.comInstagram: @healthyasamotherpodcastDr. Leah: www.womanhoodwellness.comInstagram: @drleahgordonDr. Morgan: www.milkmedicine.comInstagram: @morganmacdermottRedmond LifeRedmond Life | Real Salt & Clay | Re-Lyte Electrolyte Hydration PowderYour one stop shop for all things Redmond. We carry pure, natural sea salt and bentonite clay mined from an ancient salt deposit right here in Redmond, Utah. From Real Salt to Re-Lyte Hydration electrolyte mix, try one of our US-mined products today.needed.Radically better nutrition for fertility, pregnancy, and postpartum.Prenatal vitamins leave most women depleted, so we redesigned the Prenatal Multi from the ground-up, and paired it with the Omega-3 (DHA and EPA), Collagen Protein, and Pre/Probiotic that mamas need. Take them before, during, and after pregnancy (and while breastfeeding) for optimal prenatal and postpartum nourishment.LumeboxLUMEBOX discount linkDutch TestPrecision Analytical (DUTCH TEST) - Test Kits, Providers & PatientsExplore DUTCH Test kits for comprehensive hormone testing, provider resources, patient support, and educational webinars. Contact us for more information.

Once a Cesarean , always a Cesarean - you must have also heard this common notion. Fortunately, this is far from truth. Yet , So many women feel cornered and helpless when they become pregnant again, like the decision has already been made for them. In this episode, we're getting real about that phrase and why it's not the whole story.We get into the  actual evidence and physiology behind uterine rupture — what it is, how likely it is (with facts, not fear), and why it's also something that can happen to first-time moms. We'll also share the real advantages of choosing a VBAC over a repeat C-section, and why VBAC is worth considering — even when the system in India is yet reluctant to support itAnd if you're feeling confused, overwhelmed, or unsure what to believe — we've got you. We'll walk you through what actually makes sense and share our best advice for giving VBAC your best shot.Plus, we're giving away a Free Childbirth Guide to support you on your journey — because informed choices start with empowered information. Tune in now, share with a friend, and remember — this is your body, your baby, and your birth. You do have a voice and a Choice!Support the showSign up for Childbirth Preparation Programs! visit https://birthagni.com/services#childbirth-preparation-programs https://birthagni.com/copy-of-services#breastfeeding-preparation-program This episode is supported and made possible by podcast recording and hosting tool Zencastr, it is impeccably made! Use my link : https://zen.ai/vxmuJUgYKKGTF3JuTuFQ0g to sign up and record flawless remote podcast , USE my code : BIRTHAGNI Support the show:https://birthagni.com/birthagnipodcast#donate If you like what you hear, leave us a rating on Spotify app and answer the question at each episode! a review on Apple podcasts. Share on Whatsapp/Insta/FB Share on Instagram and tag us @divyakapoorvox ...

From unbearable pain to feeling no symptoms at all, women with uterine fibroids can have vastly different experiences. While these growths affect a large percentage of women, health advocates say they too often go undiscussed. Ali Rogin speaks with Sateria Venable, a patient advocate and CEO of The Fibroid Foundation, to learn more. PBS News is supported by - https://www.pbs.org/newshour/about/funders

Dr. John C. Lipman and Dr. Yvette White join the Bullpen for a special interview about Uterine fibroids, a condition that disproportionately affects Black women, and groundbreaking non-surgical treatment to change lives.   Host: Sharon Reed (@SharonReedLive) Bullpen guests: Dr. John C. Lipman and Dr. Yvette White *** SUBSCRIBE on ⁠⁠⁠⁠⁠⁠YOUTUBE⁠⁠⁠⁠⁠⁠  ☞ ⁠⁠⁠⁠⁠⁠ https://www.youtube.com/IndisputableTYT⁠⁠⁠⁠⁠⁠ FOLLOW US ON: ⁠⁠⁠⁠⁠⁠FACEBOOK⁠⁠⁠⁠⁠⁠  ☞ ⁠⁠⁠⁠⁠⁠  https://www.facebook.com/IndisputableTYT⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠TWITTER⁠⁠⁠⁠⁠⁠  ☞     ⁠⁠⁠⁠⁠⁠  https://www.twitter.com/IndisputableTYT⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠INSTAGRAM⁠⁠⁠⁠⁠⁠ ☞ ⁠⁠⁠⁠⁠⁠ https://www.instagram.com/IndisputableTYT⁠⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

From unbearable pain to feeling no symptoms at all, women with uterine fibroids can have vastly different experiences. While these growths affect a large percentage of women, health advocates say they too often go undiscussed. Ali Rogin speaks with Sateria Venable, a patient advocate and CEO of The Fibroid Foundation, to learn more. PBS News is supported by - https://www.pbs.org/newshour/about/funders

Bryan Kohberger pleaded guilty to murdering four University of Idaho students. During sentencing, survivors and victims' families faced him in court, including a surviving roommate who delivered powerful testimony. In an interview with Major Garrett, House Speaker Mike Johnson expressed concern over the Justice Department's handling of the Epstein case and called for full transparency and accountability. You can see more of Major Garrett's interview, along with his sharp analysis, on "The Takeout with Major Garrett," weeknights at 5 p.m. ET on CBS News 24/7. Dr. Salvador Plasencia admitted to distributing ketamine to actor Matthew Perry before his 2023 overdose. He is the fourth person to plead guilty in the case and faces up to 40 years in prison. Uterine fibroids affect up to 80% of women by age 50 and can cause painful, life-altering symptoms. Dr. Tara Shirazian joins "CBS Mornings" to discuss how diet, exercise and awareness may help. A new Charles Schwab survey finds many Americans believe they need over $800,000 to be financially comfortable, yet a third have no financial plan. CBS News business analyst Jill Schlesinger joins to explain what to do. After retiring, Erik and Karin Vonk combined their love of farming and spirits to create Richland Rum. Nearly 25 years later, their Georgia-made rum is earning high praise from critics across the globe. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Tell us your thoughts on this episode!Dr. Natalie Godbee, gynecologic oncologist at City of Hope in Atlanta, Georgia, talks with Dr. Leah Sherman in a wide-ranging interview on gynecologic cancers. The conversation covers the pros and cons of the HPV vaccine, the symptoms and risk factors for ovarian, endometrial, and cervical cancers, and the benefits of integrative medicine in cancer care. Listeners will gain valuable information on early detection, treatment options, and preventive measures for these complex cancers.Dr. Godbee's bio and links to her social mediaHuman Papillomavirus (HPV) review by the National Cancer InstituteConcerns about the safety of the HPV vaccineDoes the HPV vaccine increase promiscuity in teenagers?Dramatic reductions in pre-cancer of the cervixSupport the showOur website: https://www.thecancerpod.com Become a member of The Cancer Pod Community! Gain access to live events, exclusive content, and so much more. Join us today and be part of the journey!Email us: thecancerpod@gmail.com Follow @TheCancerPod on: Instagram Bluesky Facebook LinkedIn YouTube THANK YOU for listening!

The incidence of early onset colorectal cancer (EOCRC) has been rising prompting the change in change in screening guidelines to 45 years of age for average risk patients. Join us for an in-depth discussion with guest speakers Dr. Andrea Cercek and Dr. Nancy You, where we provide a comprehensive look at the growing challenge of EOCRC. Hosts: - Dr. Janet Alvarez - General Surgery Resident at New York Medical College/Metropolitan Hospital Center - Dr. Wini Zambare – General Surgery Resident at Weill Cornell Medical Center/New York Presbyterian - Dr. Phil Bauer, Graduating Colorectal Surgical Oncology Fellow at Memorial Sloan Kettering Cancer Center  - Dr. J. Joshua Smith MD, PhD, Chair, Department of Colon and Rectal Surgery at MD Anderson Cancer Center - Dr. Andrea Cercek - Gastrointestinal Medical Oncologist at Memorial Sloan Kettering Cancer Center - Dr. Y. Nancy You, MD MHSc - Professor, Department of Colon and Rectal Surgery at MD Anderson Cancer Center Learning objectives:  - Describe trends in incidence of colorectal cancer, with emphasis on the rise of EOCRC. - Identify age groups and demographics most affected by EOCRC. - Summarize USPSTF recommendations for colorectal cancer screening. - Distinguish between screening methods (e.g., colonoscopy, FIT-DNA) and their sensitivity. - Understand treatment approaches for colon and rectal cancer (CRC) - Understand the role of mismatch repair (MMR) status in guiding treatment. - Outline the importance of genetic counseling and testing in young patients. - Discuss racial, ethnic, and socioeconomic disparities in CRC incidence and outcomes. - Describe the impact of cancer treatment on fertility and sexual health. -  Review fertility preservation options. - Identify the value of integrated care teams for young CRC patients. References: 1.         Siegel, R. L. et al. Colorectal Cancer Incidence Patterns in the United States, 1974–2013. JNCI J. Natl. Cancer Inst. 109, djw322 (2017). https://pubmed.ncbi.nlm.nih.gov/28376186/ 2.         Abboud, Y. et al. Rising Incidence and Mortality of Early-Onset Colorectal Cancer in Young Cohorts Associated with Delayed Diagnosis. Cancers 17, 1500 (2025). https://pubmed.ncbi.nlm.nih.gov/40361427/ 3.         Phang, R. et al. Is the Incidence of Early-Onset Adenocarcinomas in Aotearoa New Zealand Increasing? Asia Pac. J. Clin. Oncol.https://pubmed.ncbi.nlm.nih.gov/40384533/ 4.         Vitaloni, M. et al. Clinical challenges and patient experiences in early-onset colorectal cancer: insights from seven European countries. BMC Gastroenterol. 25, 378 (2025). https://pubmed.ncbi.nlm.nih.gov/40375142/ 5.         Siegel, R. L. et al. Global patterns and trends in colorectal cancer incidence in young adults. (2019) doi:10.1136/gutjnl-2019-319511. https://pubmed.ncbi.nlm.nih.gov/31488504/ 6.         Cercek, A. et al. A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers. J. Natl. Cancer Inst. 113, 1683–1692 (2021). https://pubmed.ncbi.nlm.nih.gov/34405229/ 7.         Zheng, X. et al. Comprehensive Assessment of Diet Quality and Risk of Precursors of Early-Onset Colorectal Cancer. JNCI J. Natl. Cancer Inst. 113, 543–552 (2021). https://pubmed.ncbi.nlm.nih.gov/33136160/ 8.         Standl, E. & Schnell, O. Increased Risk of Cancer—An Integral Component of the Cardio–Renal–Metabolic Disease Cluster and Its Management. Cells 14, 564 (2025). https://pubmed.ncbi.nlm.nih.gov/40277890/ 9.         Muller, C., Ihionkhan, E., Stoffel, E. M. & Kupfer, S. S. Disparities in Early-Onset Colorectal Cancer. Cells 10, 1018 (2021). https://pubmed.ncbi.nlm.nih.gov/33925893/ 10.       US Preventive Services Task Force. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 325, 1965–1977 (2021). https://pubmed.ncbi.nlm.nih.gov/34003218/ 11.       Fwelo, P. et al. Differential Colorectal Cancer Mortality Across Racial and Ethnic Groups: Impact of Socioeconomic Status, Clinicopathology, and Treatment-Related Factors. Cancer Med. 14, e70612 (2025). https://pubmed.ncbi.nlm.nih.gov/40040375/ 12.       Lansdorp-Vogelaar, I. et al. Contribution of Screening and Survival Differences to Racial Disparities in Colorectal Cancer Rates. Cancer Epidemiol. Biomarkers Prev. 21, 728–736 (2012). https://pubmed.ncbi.nlm.nih.gov/22514249/ 13.       Ko, T. M. et al. Low neighborhood socioeconomic status is associated with poor outcomes in young adults with colorectal cancer. Surgery 176, 626–632 (2024). https://pubmed.ncbi.nlm.nih.gov/38972769/ 14.       Siegel, R. L., Wagle, N. S., Cercek, A., Smith, R. A. & Jemal, A. Colorectal cancer statistics, 2023. CA. Cancer J. Clin. 73, 233–254 (2023). https://pubmed.ncbi.nlm.nih.gov/36856579/ 15.       Jain, S., Maque, J., Galoosian, A., Osuna-Garcia, A. & May, F. P. Optimal Strategies for Colorectal Cancer Screening. Curr. Treat. Options Oncol. 23, 474–493 (2022). https://pubmed.ncbi.nlm.nih.gov/35316477/ 16.       Zauber, A. G. The Impact of Screening on Colorectal Cancer Mortality and Incidence: Has It Really Made a Difference? Dig. Dis. Sci. 60, 681–691 (2015). https://pubmed.ncbi.nlm.nih.gov/25740556/ 17.       Edwards, B. K. et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116, 544–573 (2010). https://pubmed.ncbi.nlm.nih.gov/19998273/ 18.       Cercek, A. et al. Nonoperative Management of Mismatch Repair–Deficient Tumors. New England Journal of Medicine 392, 2297–2308 (2025). https://pubmed.ncbi.nlm.nih.gov/40293177/ 19.       Monge, C., Waldrup, B., Carranza, F. G. & Velazquez-Villarreal, E. Molecular Heterogeneity in Early-Onset Colorectal Cancer: Pathway-Specific Insights in High-Risk Populations. Cancers 17, 1325 (2025). https://pubmed.ncbi.nlm.nih.gov/40282501/ 20.       Monge, C., Waldrup, B., Carranza, F. G. & Velazquez-Villarreal, E. Ethnicity-Specific Molecular Alterations in MAPK and JAK/STAT Pathways in Early-Onset Colorectal Cancer. Cancers 17, 1093 (2025). https://pubmed.ncbi.nlm.nih.gov/40227607/ 21.       Benson, A. B. et al. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Cancer Netw. JNCCN 19, 329–359 (2021). https://pubmed.ncbi.nlm.nih.gov/33724754/ 22.       Christenson, E. S. et al. Nivolumab and Relatlimab for the treatment of patients with unresectable or metastatic mismatch repair proficient colorectal cancer. https://pubmed.ncbi.nlm.nih.gov/40388545/ 23.       Dasari, A. et al. Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study. The Lancet 402, 41–53 (2023). https://pubmed.ncbi.nlm.nih.gov/37331369/ 24.       Strickler, J. H. et al. Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study. Lancet Oncol. 24, 496–508 (2023). https://pubmed.ncbi.nlm.nih.gov/37142372/ 25.       Sauer, R. et al. Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer. N. Engl. J. Med. 351, 1731–1740 (2004). https://pubmed.ncbi.nlm.nih.gov/15496622/ 26.       Cercek, A. et al. Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer. JAMA Oncol. 4, e180071 (2018). https://pubmed.ncbi.nlm.nih.gov/29566109/ 27.       Garcia-Aguilar, J. et al. Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy. J. Clin. Oncol. 40, 2546–2556 (2022). https://pubmed.ncbi.nlm.nih.gov/35483010/ 28.       Schrag, D. et al. Preoperative Treatment of Locally Advanced Rectal Cancer. N. Engl. J. Med. 389, 322–334 (2023). https://pubmed.ncbi.nlm.nih.gov/37272534/ 29.       Kunkler, I. H., Williams, L. J., Jack, W. J. L., Cameron, D. A. & Dixon, J. M. Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer. N. Engl. J. Med. 388, 585–594 (2023). https://pubmed.ncbi.nlm.nih.gov/36791159/ 30.       Jacobsen, R. L., Macpherson, C. F., Pflugeisen, B. M. & Johnson, R. H. Care Experience, by Site of Care, for Adolescents and Young Adults With Cancer. JCO Oncol. Pract. (2021) doi:10.1200/OP.20.00840. https://pubmed.ncbi.nlm.nih.gov/33566700/ 31.       Ruddy, K. J. et al. Prospective Study of Fertility Concerns and Preservation Strategies in Young Women With Breast Cancer. J. Clin. Oncol. (2014) doi:10.1200/JCO.2013.52.8877. https://pubmed.ncbi.nlm.nih.gov/24567428/ 32.       Su, H. I. et al. Fertility Preservation in People With Cancer: ASCO Guideline Update. J. Clin. Oncol. 43, 1488–1515 (2025). https://pubmed.ncbi.nlm.nih.gov/40106739/ 33.       Smith, K. L., Gracia, C., Sokalska, A. & Moore, H. Advances in Fertility Preservation for Young Women With Cancer. Am. Soc. Clin. Oncol. Educ. Book 27–37 (2018) doi:10.1200/EDBK_208301. https://pubmed.ncbi.nlm.nih.gov/30231357/ 34.       Blumenfeld, Z. How to Preserve Fertility in Young Women Exposed to Chemotherapy? The Role of GnRH Agonist Cotreatment in Addition to Cryopreservation of Embrya, Oocytes, or Ovaries. The Oncologist 12, 1044–1054 (2007). 35.       Bhagavath, B. The current and future state of surgery in reproductive endocrinology. Curr. Opin. Obstet. Gynecol. 34, 164 (2022). 36.       Ribeiro, R. et al. Uterine transposition: technique and a case report. Fertil. Steril. 108, 320-324.e1 (2017). 37.       Yazdani, A., Sweterlitsch, K. M., Kim, H., Flyckt, R. L. & Christianson, M. S. Surgical Innovations to Protect Fertility from Oncologic Pelvic Radiation Therapy: Ovarian Transposition and Uterine Fixation. J. Clin. Med. 13, 5577 (2024). 38.       Holowatyj, A. N., Eng, C. & Lewis, M. A. Incorporating Reproductive Health in the Clinical Management of Early-Onset Colorectal Cancer. JCO Oncol. Pract. 18, 169–172 (2022). ***Behind the Knife Colorectal Surgery Oral Board Audio Review: https://app.behindtheknife.org/course-details/colorectal-surgery-oral-board-audio-review Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Uterine incarceration in pregnancy, is a rare but troublesome complication. This occurs when a retroverted uterus becomes trapped in the pelvic cavity during pregnancy. This happens when the uterus fails to move forward as it grows, becoming stuck between the sacral promontory and pubicsymphysis. It's more common in women with prior pelvic issues or uterine anomalies. Urinary retention is the most common symptom that occurs because of elongation of the urethra by displacement of the cervix, loss of the urethro-vesical angle, and mechanical compression of the bladder neck. It is estimated to occur in 1 in 3000 patients. How do we release an incarcerated uterus? Is laparoscopy an option? And how can an ultrasound probe help (April 2025publication)? Listen in for details.

It's Prostate Week in Podcastistan: what happens when an MRI scan for prostatitis includes the injection of rare earth metals—should you, or shouldn't you? Gadolinium crosses the blood-brain barrier if the barrier is not fully intact—does that affect your decision? Then: a letter from an MD-PhD student at Harvard prompts musings on the federal funding of science, what science is for, how complicit universities and many scientists have been for years, and what to do. Also: uterine transplants for “trans women.”*****Our sponsors:Timeline: Accelerate the clearing of damaged mitochondria to improve strength and endurance: Go to http://www.timeline.com/darkhorse and use code darkhorse for 10% off your first order.Caraway: Non-toxic & beautiful cookware. Save $150 on a cookware set over buying individual pieces, and get 10% off your order at http://Carawayhome.com/DarkHorse10.ARMRA Colostrum is an ancient bioactive whole food that can strengthen your immune system. Go to http://www.tryarmra.com/DARKHORSE to get 15% off your first order.*****Join us on Locals! Get access to our Discord server, exclusive live streams, live chats for all streams, and early access to many podcasts: https://darkhorse.locals.comHeather's newsletter, Natural Selections (subscribe to get free weekly essays in your inbox): https://naturalselections.substack.comOur book, A Hunter-Gatherer's Guide to the 21st Century, is available everywhere books are sold, including from Amazon: https://amzn.to/3AGANGg (commission earned)Check out our store! Epic tabby, digital book burning, saddle up the dire wolves, and more: https://darkhorsestore.org*****Mentioned in this episode:Gadolinium Contrast Dye: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-gadolinium-based-contrast-agents-gbcas-are-retained-bodyLetter from Harvard: https://naturalselections.substack.com/p/letter-from-harvard/commentsHigher Education Research & Development Survey: https://ncses.nsf.gov/surveys/higher-education-research-development/2023#dataJones et al 2018. Uterine transplantation in transgender women. Bjog 126(2): 152-156: https://pmc.ncbi.nlm.nih.gov/articles/PMC6492192/pdf/BJO-126-152.pdfSupport the show

Send us a textWhat's the one question every woman wants to answer when considering a VBAC? Is it safe for me and my baby? In today's episode, Cynthia & Trisha break down the available data on VBAC, why we should discard the term TOLAC, the actual risks of uterine rupture, whether induced with Pitocon versus a prostaglandin or having spontaneous labor versus expectant management. We present the few cases in which a woman should not choose to VBAC and help mothers understand their decisions should not be driven by statistics alone. If you are considering a VBAC, get a pen and paper and arm yourself with all the stats from this data-rich dialogue. Also: Let's get HavBAC to take! (Inside Joke -- you'll get it when you listen!)**********Watch the full videos of all our episodes on YouTube!**********Our sponsors:Silverette Nursing Cups -- Soothe and heal sore nipples with 925 silver nursing cups.Postpartum Soothe -- Herbs and padsicles to heal and comfort.Needed -- Our favorite nutritional products for before, during, and after pregnancy. Use this link to save 20%DrinkLMNT -- Purchase LMNT with this unique link and get a FREE sample packENERGYbits--the superfood every mother needs for pregnancy, postpartum, and breastfeedingPrimally Pure: From soil to skin, primally pure products are made with down-to-earth ingredients that feel and smell like heaven for the skinUse promo code: DOWNTOBIRTH for all sponsors.Connect with us on Patreon for our exclusive content.Email Contact@DownToBirthShow.comInstagram @downtobirthshowCall us at 802-GET-DOWN Watch the full videos of all our episodes on YouTube! Work with Cynthia: 203-952-7299 HypnoBirthingCT.com Work with Trisha: 734-649-6294 Please remember we don't provide medical advice. Speak to your licensed medical provider for all your healthcare matters.